Metabolic studies of human primitive neuroectodermal tumour cells by proton nuclear magnetic resonance spectroscopy

被引:8
|
作者
Florian, CL
Pietsch, T
Noble, M
Williams, SR
机构
[1] INST CHILD HLTH,ROYAL COLL SURG ENGLAND,BIOPHYS UNIT,LONDON WC1N 1EH,ENGLAND
[2] UNIV BONN,INST NEUROPATHOL,MED EINRICHTUNGEN,D-53105 BONN,GERMANY
[3] LUDWIG INST CANC RES,LONDON W1P 8BT,ENGLAND
关键词
human primitive neuroectodermal tumour; human medulloblastoma; proton nuclear magnetic resonance spectroscopy; metabolite; cell line; BRAIN-TUMORS; MR SPECTROSCOPY; RAT-BRAIN; IN-VIVO; MEDULLOBLASTOMA; CHILDHOOD; ACID; DIFFERENTIATION; CLASSIFICATION; ESTABLISHMENT;
D O I
10.1038/bjc.1997.173
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Well-characterized cell lines established from primitive neuroectodermal rumours (PNETs) were examined by proton nuclear magnetic resonance (H-1-NMR) spectroscopy and chromatographic analysis of perchloric acid extracts, following amplification in cell culture. A characteristic H-1-NMR spectroscopic metabolite pattern was found for medulloblastoma cell lines, which clearly discriminates these cells from PNETs of other locations in the central nervous system (CNS), on the basis of their N-acetyl aspartate (NAA) and aspartate expression. Medulloblastoma cell lines were heterogeneous in respect of their metabolite expression, possibly owing to the heterogeneity in their differentiation along lineages of the CNS. All PNET spectra displayed similar features, including decreased NAA and creatine peaks and increased signals from choline compounds (Cho) compared with normal cerebellum. The expression of NAA by the medulloblastoma lines was in the opposite order to the extent of neuronal differentiation, which may indicate their origin from a progenitor cell with the phenotype of an oligodendrocyte-type-2 astrocyte cell.
引用
收藏
页码:1007 / 1013
页数:7
相关论文
共 50 条
  • [41] Proton magnetic resonance spectroscopy of the human brain in schizophrenia
    Deicken, RF
    Johnson, C
    Pegues, M
    REVIEWS IN THE NEUROSCIENCES, 2000, 11 (2-3) : 147 - 158
  • [42] In vitro proton magnetic resonance spectroscopy of liver tissue informs in vivo hepatic proton magnetic resonance spectroscopy studies -: Reply
    Johnson, Nathan A.
    Sachinwalla, Toos
    George, Jacob
    HEPATOLOGY, 2008, 48 (03) : 1016 - 1017
  • [43] PROTON NUCLEAR MAGNETIC-RESONANCE STUDIES OF SPECTRIN FROM HUMAN-ERYTHROCYTES
    SIMA, PD
    JOHNSON, ME
    FUNG, LWM
    BIOPHYSICAL JOURNAL, 1984, 45 (02) : A240 - A240
  • [44] HIGH-RESOLUTION PROTON NUCLEAR MAGNETIC-RESONANCE STUDIES OF HUMAN GASTRIN
    TORDA, AE
    BALDWIN, GS
    NORTON, RS
    BIOCHEMISTRY, 1985, 24 (07) : 1720 - 1727
  • [45] PROTON NUCLEAR MAGNETIC-RESONANCE STUDIES OF OXYGENATION OF HUMAN ADULT HEMOGLOBIN IN WATER
    VIGGIANO, G
    HO, C
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 755 - 755
  • [46] Revealing Different Lung Metastatic Potentials Induced Metabolic Alterations of Hepatocellular Carcinoma Cells via Proton Nuclear Magnetic Resonance Spectroscopy
    Chen, Yang
    Lin, Donghong
    Chen, Zhong
    Feng, Jianghua
    Liao, Naishun
    JOURNAL OF CANCER, 2018, 9 (24): : 4696 - 4705
  • [47] Proton nuclear magnetic resonance and optical microscopic studies of magnetic fluids
    Saito, SH
    Ohaba, M
    JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN, 1999, 68 (04) : 1357 - 1363
  • [48] Proton and phosphorus-31 nuclear magnetic resonance spectroscopy of human bile in hepatopancreaticobiliary cancer
    Khan, SA
    Cox, IJ
    Thillainayagam, AV
    Bansi, DS
    Thomas, HC
    Taylor-Robinson, SD
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (07) : 733 - 738
  • [49] IN-VIVO MEASUREMENT OF PHENYLALANINE IN HUMAN BRAIN BY PROTON NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY
    NOVOTNY, EJ
    AVISON, MJ
    HERSCHKOWITZ, N
    PETROFF, OAC
    PRICHARD, JW
    SEASHORE, MR
    ROTHMAN, DL
    PEDIATRIC RESEARCH, 1995, 37 (02) : 244 - 249
  • [50] METABOLIC STUDIES OF ESTROGEN-TREATED AND TAMOXIFEN-TREATED HUMAN-BREAST CANCER-CELLS BY NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY
    NEEMAN, M
    DEGANI, H
    CANCER RESEARCH, 1989, 49 (03) : 589 - 594